Type 1 Diabetes Segment to Dominate the United States Insulin Pumps Market
Increasing demand for minimally invasive
treatment and rise in chronic disorders is expected to drive the United States insulin
pumps market for the forecast period.
According to TechSci Research report, “United
States Insulin Pumps Market By Type (Traditional Insulin Pumps v/s Patch
Pumps) By Insulin Used (Short Acting Insulin v/s Rapid Acting Insulin) By
Application (Type 1 Diabetes v/s Type 2 Diabetes) By End User (Hospitals &
Clinics, Diagnostic Centers, Home Care), By Region, Company Forecast &
Opportunities, 2026”, the United States insulin pumps market is expected to
witness significant growth for the next five years. Insulin pump are medical
devices used to administer the insulin level present in body to control
diabetes. Rise in people suffering from diabetes and surge in awareness
regarding the benefits of using insulin pumps is a contributing factor expected
to strengthen the market. Insulin pumps can be easily controlled by pushing
buttons and the biggest advantage of using insulin pumps is that it can be set
to deliver insulin with different rates at different time of the day according
to the need of the individual. Using insulin pumps is very easy and causes less
difficulty while delivering insulin to the human body therefore it provides
more flexibility to choose the desired food item without the fear of needles.
Rapidly changing
lifestyle and consumption of alcohol and smoking causing diabetes is expected
to accelerate the demand for insulin pumps. Change in dietary preference coupled
with growing preference for packaged food and ready to eat food items
containing preservatives and artificial ingredients is affecting the health
adversely. Favorable reimbursement policies offered by government to promote
healthcare industry is expected to propel the demand of insulin pumps in United
States.
The COVID-19 outbreak across the world which has
been declared as pandemic by World Health Organization has affected several countries
adversely. Leading authorities in United States imposed lockdown restrictions
and released a set of precautionary measures to contain the spread of novel
coronavirus. United States authorities increased the capacity of hospitals as a
greater number of patients were getting affected daily and getting admitted
into the hospital facilities. Rise in cases of people suffering from diabetes
boosted the sales of insulin pumps. Diabetic people are indulging through
various modes such as hospital pharmacies, medical shops and through online
channels to buy critical medical devices.
However, side-effects of insulin pumps such as
skin infections and high cost of insulin pumps may create hindrance in the growth
of the insulin pumps market.
Browse XX Figures spread through XX Pages and an in-depth
TOC on "United States Insulin
Pumps Market”.
https://www.techsciresearch.com/report/united-states-insulin-pumps-market/7589.html
United States insulin
pumps market is segmented into type, insulin used, application, end user, regional
distribution, and company. Based on type, market can be divided into traditional
insulin pumps and patch pumps. The traditional insulin pumps type segment is
expected to account for major market share for the forecast period, 2022-2026.
These are readily available in the market and highly reliable in nature. Based
on application, market can be divided into type 1 diabetes and type 2 diabetes.
The type 1 diabetes application segment is expected to dominate the market for
the next five years due to rising prevalence of type 1 diabetes. Patients
suffering from type 1 diabetes are not able to produce insulin in their body by
themselves therefore need for insulin pumps is highest for this segment.
Medtronic USA,
Inc, Roche Diagnostics Corporation, Becton, Dickinson and Company, B. Braun
Medical Inc., Abbott Laboratories, Inc., Insulet Corporation, Tandem Diabetes
Care, Inc., Nipro Medical Corporation are the leading players operating in United
States insulin pumps market. Manufacturers are increasingly focusing on research
and development process to fuel higher growth in the market. To meet evolving
customer demand with respect to better efficiency and durability, several insulin
pumps manufacturers are coming up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7589
Customers can also
request for 10% free customization on this report.
“Market players are focusing on research and
development activities to advance the existing infrastructure of insulin pumps
and develop new generation insulin pumps. These new generation insulin pumps
are safe, convenient, provide precise results and the integration with digital
technology enables patient to address the health-related issues remotely and
share the patient’s data for proper treatment. Home infusion therapy and
artificial pancreas are some of the technological advancements which is
expected to fuel the demand for insulin pumps in United States. Adoption of
smart technologies such as artificial intelligence and machine learning can
improve the performance of insulin pumps and prevent the need for rapid
re-adjustments which is expected to propel the demand for insulin pump till
2026” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
“United States Insulin
Pumps Market By Type (Traditional Insulin Pumps v/s Patch Pumps) By Insulin
Used (Short Acting Insulin v/s Rapid Acting Insulin) By Application (Type 1
Diabetes v/s Type 2 Diabetes) By End User (Hospitals & Clinics, Diagnostic
Centers, Home Care), By Region, Company Forecast & Opportunities, 2026” has evaluated the
future growth potential of United States insulin pumps market and provided
statistics & information on market size, shares, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers, challenges,
and opportunities in the of United States insulin pumps market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/